Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.

Translated title of the contribution: Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.
  • F.V. van Venrooij
  • , M.A. van der Ree
  • , M.L. Bots
  • , R.P. Stolk
  • , M.V. Huisman
  • , J.D. Banga

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionAggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial.
Original languageUndefined/Unknown
Pages (from-to)1211-1216
Number of pages6
JournalDiabetes Care
Volume25
Publication statusPublished - 2002

Cite this